MedPath

Combination chemotherapy with methotrexate and vinblastine for surgically unresectable, aggressive desmoid tumor

Not Applicable
Conditions
desmoid tumor
Registration Number
JPRN-UMIN000030998
Lead Sponsor
Kanazawa University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
6
Inclusion Criteria

Not provided

Exclusion Criteria

contraindication for methotrexate or vinblastine, severe heart disease, renal dyfunction, respiratory failure, caogulation disorder pregnant Other medical, social, or psychological conditions that in the opinion of an investigator precludes the patient from appropriate consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath